ACNOCELL™
- ACNOCELL
Biomimetic Antimicrobial Peptide Technology for Acne-Prone Skin
ACNOTIDE is a next-generation granulysin-like antimicrobial peptide developed to support clearer, calmer, and more balanced acne-prone skin through a biomimetic, non-antibiotic mechanism.
Designed as part of the ACNOCELL professional system, ACNOTIDE addresses the core visible challenges of acne-affected skin — microbial imbalance, inflammatory lesions, and barrier vulnerability — while respecting the skin’s natural defense mechanisms.
Formulation Philosophy
ACNOTIDE formulations are built around a biomimetic antimicrobial peptide and supported by complementary cosmetic actives, including soothing, hydrating, and barrier-supporting components, as well as microbiome-friendly ingredients.
The peptide is effective at very low concentrations, allowing formulations to achieve visible purification and calming effects without aggressive agents or antibiotic stress. This approach supports long-term skin comfort, tolerance, and maintenance use.
This multi-level formulation strategy allows ACNOTIDE to address acne-prone skin comprehensively — supporting purification, barrier stability, and post-inflammatory balance within one coherent cosmetic system.
A New Peptide Approach to Acne Care
Unlike traditional anti-acne solutions that rely on antibiotics or harsh antimicrobial agents, ACNOTIDE is based on a granulysin-inspired peptide structure, modeled after the skin’s own innate immune defense.
This peptide acts directly on bacterial cell membranes, leading to disruption and osmotic lysis of acne-associated microorganisms. This physical membrane-targeting mechanism makes the development of bacterial resistance unlikely and allows ACNOTIDE to be considered a cosmetic alternative to antibiotic-based approaches.
The peptide shows activity against gram-positive and gram-negative bacteria, including P. acnes, while maintaining skin tolerance and comfort.
How ACNOTIDE system Works
ACNOTIDE acts at the skin surface and within the follicular environment, where acne-related processes originate.
By helping reduce microbial imbalance and supporting anti-inflammatory pathways, the peptide contributes to a visible reduction in inflammatory lesions and promotes a calmer skin state. At the same time, peptide supports the skin’s protective barrier, helping prevent excessive dryness, irritation, or rebound oiliness often associated with conventional acne treatments.
This approach makes ACNOTIDE peptide suitable not only for active breakouts, but also for long-term maintenance during remission.
Visible Skin Response
In professional use, ACNOTIDE peptide are associated with visible improvements in skin clarity, reduction of inflammatory elements, and improved overall skin comfort.
In a cosmetic in-use evaluation of a topical formulation containing a suitable-dose granulysin-derived peptide applied twice daily for 12 weeks, participants with facial acne demonstrated a reduction in lesion count across different acne severities.
With continued use, the skin appears more balanced, less reactive, and more resilient, with a reduced tendency toward new breakouts. Importantly, ACNOTIDE peptide does not promote bacterial resistance, making it suitable for repeated and long-term cosmetic use.
ACNOCELL – From Professional Treatments to Home Care
ACNOCELL line with ACNOTIDE peptide is used across professional procedures and daily home-care products. This continuity allows the skin to receive consistent support during active treatment phases and helps maintain visible results between professional sessions.
{Responsible cosmetic use note}
ACNOTIDE is the anti acne peptide in ACNOCELL line is a cosmetic peptide technology intended to improve the appearance and balance of acne-prone skin. It is not a medical product and does not diagnose, treat, or prevent disease.